1. Methamphetamine detection using portable capillary electrophoresis coupled with a swab-based extraction device.
- Author
-
Atia MA, Kalsoom U, Ollerton S, Haddad PR, and Breadmore MC
- Subjects
- Humans, Limit of Detection, Pseudoephedrine analysis, Pseudoephedrine isolation & purification, Substance Abuse Detection methods, Substance Abuse Detection instrumentation, Illicit Drugs analysis, Illicit Drugs isolation & purification, Methamphetamine analysis, Methamphetamine isolation & purification, Electrophoresis, Capillary methods
- Abstract
Methamphetamine (MA) is one of the most virulent illicit drugs that can be synthesized from household materials leading to its prevalent trafficking and local manufacturing in clandestine drug laboratories (clan labs). The significant problems of tracing MA in clan labs and monitoring drug abusers lie in the lag time between sample collection and analysis and the number of tests done. Capillary electrophoresis (CE) is a rapid separation technique amenable to miniaturization and field testing. Herein, we developed a simple transient isotachophoretic (tITP)-CE method to detect MA and its precursor pseudoephedrine (PSE) in clan labs and non-invasive biological fluids. The method was implemented on the ETD-100, a commercial fully automated portable CE instrument with an integrated swab-based extraction system. Within 2 min of insertion of the swab, MA and PSE were automatically extracted with a leading electrolyte (LE) and then separated on covalently modified capillaries. The ETD-100 showed a limit of detection (LOD) and quantification (LOQ) of MA 0.02 and 0.05 μg/swab and 0.02 and 0.06 μg/swab of PSE, with an enhancement factor of 118 and 328, respectively, when compared to a normal non-tITP injection. The intra and inter-day relative standard deviation in terms of migration time were in the range of 0.75-1.93 % for both MA and PSE and were 2.0-2.4 % for both MA and PSE peak height. The method was demonstrated with the detection of spiked MA and PSE on different household materials as well as in non-invasive biological fluids with a recovery above 60 %., Competing Interests: Declaration of competing interest Research Support:The authors report that financial support was provided by the University of Tasmania and Pfizer Global research and Development. Equipment and Technical support was provided by Grey Scan., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF